Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001065377 | SCV001230333 | benign | Intellectual disability, autosomal dominant 6; Developmental and epileptic encephalopathy, 27 | 2024-10-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004030581 | SCV004877937 | uncertain significance | Inborn genetic diseases | 2024-02-21 | criteria provided, single submitter | clinical testing | The c.3338C>T (p.P1113L) alteration is located in exon 13 (coding exon 12) of the GRIN2B gene. This alteration results from a C to T substitution at nucleotide position 3338, causing the proline (P) at amino acid position 1113 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |